These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 33024354)

  • 1. Bioinformatical study on the proteomics and evolution of SARS-CoV.
    Liu S; Guo T; Ji X; Sun Z
    Chin Sci Bull; 2003; 48(13):1277-1287. PubMed ID: 32214704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory Microbial Co-infection With SARS-CoV-2.
    Massey BW; Jayathilake K; Meltzer HY
    Front Microbiol; 2020; 11():2079. PubMed ID: 32983056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2.
    Zhu J; Kim J; Xiao X; Wang Y; Luo D; Jiang S; Chen R; Xu L; Zhang H; Moise L; Gutierrez AH; De Groot AS; Xiao G; Schoggins JW; Zhan X; Wang T; Xie Y
    bioRxiv; 2020 Sep; ():. PubMed ID: 32908981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phylogeny of SARS-CoV as inferred from complete genome comparison.
    Qi Z; Hu Y; Li W; Chen Y; Zhang Z; Sun S; Lu H; Zhang J; Bu D; Ling L; Chen R
    Chin Sci Bull; 2003; 48(12):1175-1178. PubMed ID: 32214702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience.
    Huang J; Zheng M; Tang X; Chen Y; Tong A; Zhou L
    Front Neurol; 2020; 11():659. PubMed ID: 32625165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?
    Kim SJ; Nguyen VG; Park YH; Park BK; Chung HC
    Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32422894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenomic proximity and comparative proteomic analysis of SARS-CoV-2.
    Prathiviraj R; Kiran GS; Selvin J
    Gene Rep; 2020 Sep; 20():100777. PubMed ID: 32835133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
    Park SE
    Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular immune pathogenesis and diagnosis of COVID-19.
    Li X; Geng M; Peng Y; Meng L; Lu S
    J Pharm Anal; 2020 Apr; 10(2):102-108. PubMed ID: 32282863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.
    Benazzo M; Cassaniti I; Maiorano E; Calastri A; Novazzi F; Bonetti A; Sarasini A; Bruno R; Baldanti F
    Microorganisms; 2020 Jul; 8(7):. PubMed ID: 32679910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of Initial Available SARS-CoV-2 Sequences from Iranian Related COVID-19 Patients.
    Salehi N; Amiri-Yekta A; Totonchi M
    Cell J; 2020 Jul; 22(Suppl 1):148-150. PubMed ID: 32779445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.
    Pruijssers AJ; George AS; Schäfer A; Leist SR; Gralinksi LE; Dinnon KH; Yount BL; Agostini ML; Stevens LJ; Chappell JD; Lu X; Hughes TM; Gully K; Martinez DR; Brown AJ; Graham RL; Perry JK; Du Pont V; Pitts J; Ma B; Babusis D; Murakami E; Feng JY; Bilello JP; Porter DP; Cihlar T; Baric RS; Denison MR; Sheahan TP
    bioRxiv; 2020 Apr; ():. PubMed ID: 32511392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells.
    Ma M; Badeti S; Geng K; Liu D
    bioRxiv; 2020 Aug; ():. PubMed ID: 32817942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
    Orhan IE; Senol Deniz FS
    Nat Prod Bioprospect; 2020 Aug; 10(4):171-186. PubMed ID: 32529545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SARS-CoV-2].
    Steinbauer M; Böckler D
    Gefasschirurgie; 2020; 25(6):387-388. PubMed ID: 33024354
    [No Abstract]   [Full Text] [Related]  

  • 16. Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2.
    Shirvani E; Samal SK
    Pathogens; 2020 Jul; 9(8):. PubMed ID: 32751194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA MAb blocks SARS-CoV-2 Spike-ACE2 interaction providing mucosal immunity.
    Ejemel M; Li Q; Hou S; Schiller ZA; Wallace AL; Amcheslavsky A; Yilmaz NK; Toomey JR; Schneider R; Close BJ; Chen DY; Conway HL; Mohsan S; Cavacini LA; Klempner MS; Schiffer CA; Wang Y
    bioRxiv; 2020 May; ():. PubMed ID: 32511396
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.